Delivery Order SPE2DB22D3301-SPE2DB25FY8JP
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,667.16 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. This contract is for the supply of 4565818463 ULTANE 250 ML PEN BOTTLE 250ML, a pharmaceutical product, with an ultimate completion date of September 17, 2024. The contract is not set aside and serves as a delivery order against a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between...
- This is a $1,155.12 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ULTANE 250 ML PEN BOTTLE 250ML medical products, with a period of performance through April 14, 2025. The contract is a firm fixed-price type and was not set aside for any specific business category. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Ultane 250 ML Pen Bottle 250ML. The contract has a ceiling value of $2,778.60 and a period of performance through April 2, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential value of up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 250 ML pen bottles of the pharmaceutical product ULTANE. The contract has a completion date of February 1, 2024 and a potential value of $1,157.75. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is issued under a larger indefinite delivery contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,111.44 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of ULTANE 250 ML PEN BOTTLE 250ML pharmaceutical products and has a performance period through March 29, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) from DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,706.01 firm fixed-price delivery order is for the supply of Ultane Liquid, a 250 mL medication. The contract has a performance period through May 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,686.99, is for the delivery of Ultane 250 ML Pen Bottles. The contract has a completion date of February 7, 2025, and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract, valued at $1,892.36, is for the supply of ULTANE 250 ML PEN BOTTLE 250ML, a pharmaceutical product. The contract has an ultimate completion date of August 28, 2024 and is a Firm Fixed Price type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,124.48 firm fixed-price delivery order is for the supply of ULTANE LIQ 250ML 1S medical products. The contract has an ultimate completion date of July 3, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ULTANE 250 ML PEN BOTTLE 250ML, with a ceiling value of $2,406.50 and a period of performance through June 6, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY8JPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ultane 250 ML pen bottles. This firm fixed-price delivery order, valued at $1,299.51, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), an agreement valued at $999.999 billion through December 2026. The contract involves no set-aside designation and was competitively awarded through standard federal procurement processes. Performance is scheduled for completion by July 28, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a comprehensive pharmaceutical supplier registered in the System for Award Management, the company maintains an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Ultane represents one component of AmerisourceBergen's ongoing fulfillment of medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its prime vendor agreement with DLA Troop Support Medical.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/25/25 |